Press Releases
-
Mundipharma and Vectura announce plans to reformulate flutiform® (fluticasone propionate/formoterol fumarate) pressurised metered-dose inhaler (pMDI) as a commitment to reducing the product’s carbon footprint
The two companies have entered into a collaboration agreement to continue the development work of incorporating an environmentally friendly propellant into the formulation of flutiform® (fluticasone propionate/formoterol fumarate) used in a pressurised metered-dose inhaler (pMDI).
Apr 15, 2024
-
PathAI Partners with Google Cloud to Transform Drug Discovery and Precision Medicine Through AI-Powered Pathology
PathAI, a global leader in AI-powered pathology, today announced a strategic partnership with Google Cloud at Bio-IT World Conference & Expo to help biopharma companies and anatomic pathology (AP) labs accelerate the adoption of AI and digital pathology.
Apr 15, 2024
-
Julie Blasingim Promoted to Chief Executive Officer of Univo IRB
-
Arvinas Enters into a Transaction with Novartis, including a Global License Agreement for the Development and Commercialization of PROTAC® Androgen Receptor (AR) Protein Degrader ARV-766 for the Treatment of Prostate Cancer
-
Amerigo Scientific Supplies Environmental Sampling Bootie for Salmonella and Environment Monitoring
-
Cresset® Creates New Vice President Role to Lead their Artificial Intelligence (AI) Strategy
Drug discovery specialists Cresset have announced a major new hire in their senior leadership team with the appointment of Dr. Mutlu Dogruel as Vice President of AI Solutions.
Apr 14, 2024
-
Ace Neuroscience Unveils Integrated Drug Development Services for Stroke
Ace Neuroscience announces the launch of its integrated drug development services specifically designed for preclinical research on stroke.
Apr 14, 2024
-
CD BioSciences Announces Peptidomimetic Drug Screening Service to Accelerate Modern Drug Discovery
-
Qinecsa Host Industry Discussion on Mastering Medical Device Regulations to Integrate Devices into Pharma Portfolios
Qinecsa Solutions (Qinecsa), specialists in technology-led end-to-end pharmacovigilance solutions, will present an in-depth exploration of medical device regulations, for pharmacovigilance professionals seeking mastery in compliance and operational excellence.
Apr 10, 2024
-
ImpediMed to Present Chronic Breast Cancer-related Lymphedema Study Results at American Society of Breast Surgeons Annual Meeting
-
BOC Sciences to Present Its Novel Solutions at the 2024 TIDES USA Conference
BOC Sciences, a globally renowned supplier with over a decade of experience in the biochemical supply chain, is thrilled to announce its participation in this year's TIDES USA or the Oligonucleotide and Peptide Therapeutics conference. The BOC Sciences team will showcase its cutting-edge products and services at booth #937.
Apr 10, 2024
-
Alfa Chemistry: Enhancing Thin Layer Chromatography (TLC) Capabilities with New Derivatization Reagents
Alfa Chemistry, a reliable chemical supplier, is pleased to announce the addition of a comprehensive range of derivatization reagents for use in Thin Layer Chromatography (TLC). These reagents are specifically designed to enhance the detection and analysis of compounds on TLC plates, enabling researchers to achieve better results in their experiments.
Apr 11, 2024
-
Rapid increase in purchasing teams expected at CPHI North America
-
Qinecsa Solutions announces acquisition of Insife to expand its end-to-end pharmacovigilance technology solutions
Qinecsa Solutions (Qinecsa), specialists in technology-led end-to-end pharmacovigilance solutions, proudly announces its acquisition of Insife ApS (Insife), a well-established Danish-based software, technology, and consultancy firm specializing in developing revolutionary pharmacovigilance platforms.
Apr 10, 2024
-
ProPharma Announces Changes to Its Executive Leadership Team to Propel Growth
ProPharma announces changes to its executive leadership team with strategic leadership appointments to propel global growth
Apr 9, 2024
-
Cambridge Cognition strengthens senior management team to deliver growth
Cambridge Cognition, a leader in digital health solutions for brain health assessment, has announced the appointments of Alex Livingstone-Learmonth as Chief Commercial Officer and Annabelle Miles as Head of Marketing.
Apr 9, 2024
-
Bios Health Group Unveils Bios Innovation Circle™
Bios Health Group Unveils Bios Innovation Circle™ Groundbreaking venture studio and strategic hub empowers members with comprehensive arsenal of benefits to dominate the life sciences arena
Apr 8, 2024
-
Andaman7 Launches AI Supercharged Personal Health Record v5
Andaman7 Launches AI Supercharged Personal Health Record v5 New advanced AI Simplification, Summarization and Translation features empower patients and improve communication with healthcare providers and researchers.
Apr 3, 2024
-
LogiPharma Highlights Key Sponsors for 2024 Event
With LogiPharma, the world’s leading life sciences supply chain event, only weeks away, organisers are highlighting some of the sponsors and exhibitors who are key to building the event’s reputation as a platform for building industry connections across the airline, logistics, and pharmaceutical sectors.
Apr 3, 2024
-
Scope of Industry Risk-Based Quality Management (RBQM) Adoption Revealed
Scope of Industry Risk-Based Quality Management (RBQM) Adoption Revealed CluePoints, the Tufts Center for the Study of Drug Development and PwC publish Comprehensive Assessment of RBQM Adoption in Clinical Trials.
Apr 1, 2024